Ilyas Sahin
oncologistMale0.0Global Dominance: 0.00%
Ilyas Sahin is an oncologist known for his work in clinical trials for cancer treatments. He is a co-director of trials involving BO-112, which have shown promising results in patients with melanoma resistant to immunotherapy, and he actively shares advancements in cancer therapy on social media.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Ilyas Sahin is an oncologist who celebrated the promising results of a clinical trial for melanoma treatment.
La odisea de tres mujeres y el BO-112, la molécula que engaña al cáncer | CienciaEl País·
Spain· 2025-08-03
Spain· 2025-08-03
